Recursion Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/11/2025 | 34.01 M | $229.91 M | 40.12% | 12.04% |
| ARK INVESTMENT MANAGEMENT LLC | 02/04/2025 | 32.35 M | $218.66 M | -1.29% | 11.45% |
| BAILLIE GIFFORD & CO | 01/31/2025 | 24.86 M | $168.08 M | -1.49% | 8.80% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 23.44 M | $158.43 M | 12.99% | 8.29% |
| SOFTBANK GROUP CORP. | 02/14/2025 | 14.67 M | $99.15 M | 100.00% | 5.19% |
| MUBADALA INVESTMENT CO PJSC | 02/14/2025 | 12.99 M | $87.78 M | 0.00% | 4.60% |
| KINNEVIK AB (PUBL) | 01/23/2025 | 11.91 M | $80.48 M | 0.00% | 4.21% |
| NOVO HOLDINGS A/S | 02/14/2025 | 10.11 M | $68.37 M | 100.00% | 3.58% |
| MIC CAPITAL MANAGEMENT UK LLP | 02/14/2025 | 9.64 M | $65.19 M | 14.11% | 3.41% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/28/2025 | 8.98 M | $60.71 M | -8.05% | 3.18% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 02/10/2025 | 8.91 M | $60.13 M | -8.11% | 3.15% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 7.73 M | $52.22 M | -49.79% | 2.73% |
| NVIDIA CORP | 02/14/2025 | 7.71 M | $52.10 M | 0.00% | 2.73% |
| FMR LLC | 02/13/2025 | 7.07 M | $47.81 M | -15.44% | 2.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 6.09 M | $41.16 M | 12.06% | 2.15% |
| DATA COLLECTIVE IV GP, LLC | 02/14/2025 | 5.94 M | $40.16 M | 0.00% | 2.10% |
| DCVC OPPORTUNITY FUND II GP, LLC | 02/14/2025 | 3.95 M | $26.71 M | 0.00% | 1.40% |
| EXOR CAPITAL LLP | 02/04/2025 | 3.68 M | $24.84 M | 0.00% | 1.30% |
| NORGES BANK | 02/12/2025 | 3.47 M | $23.43 M | 100.00% | 1.23% |
| UBS GROUP AG | 02/14/2025 | 3.00 M | $20.31 M | 275.65% | 1.06% |
| LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 2.46 M | $16.61 M | 100.00% | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 2.32 M | $15.65 M | 0.00% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 2.27 M | $15.37 M | 17.18% | 0.80% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 2.26 M | $15.27 M | 5.53% | 0.80% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.07 M | $13.96 M | 34.13% | 0.73% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.71 M | $11.55 M | -0.57% | 0.60% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.67 M | $11.27 M | 55.85% | 0.59% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 1.66 M | $11.23 M | 3.96% | 0.59% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.14 M | $7.74 M | 13.50% | 0.41% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 1.07 M | $7.23 M | -4.79% | 0.38% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.06 M | $7.15 M | -10.12% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 991,900 | $6.71 M | 67.69% | 0.35% |
| COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 02/14/2025 | 941,895 | $6.37 M | 0.00% | 0.33% |
| LIONTRUST INVESTMENT PARTNERS LLP | 02/13/2025 | 931,727 | $6.30 M | -5.89% | 0.33% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 850,636 | $5.75 M | -8.15% | 0.30% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 02/06/2025 | 845,154 | $6.36 M | 15.31% | 0.30% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 02/11/2025 | 733,011 | $4.96 M | 293.92% | 0.26% |
| WOODLINE PARTNERS LP | 02/14/2025 | 670,867 | $4.54 M | -0.07% | 0.24% |
| NAN FUNG GROUP HOLDINGS LTD | 02/13/2025 | 664,610 | $4.49 M | 100.00% | 0.24% |
| BARCLAYS PLC | 02/13/2025 | 633,125 | $4.28 M | -9.22% | 0.22% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2025 | 595,518 | $4.03 M | 100.00% | 0.21% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 595,472 | $4.03 M | -11.89% | 0.21% |
| INSTITUTE FOR WEALTH MANAGEMENT, LLC. | 01/23/2025 | 580,997 | $3.93 M | 100.00% | 0.21% |
| LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 555,850 | $3.76 M | -13.46% | 0.20% |
| CITIGROUP INC | 02/12/2025 | 500,988 | $3.39 M | 162.64% | 0.18% |
| SWISS NATIONAL BANK | 02/10/2025 | 486,700 | $3.29 M | 36.29% | 0.17% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 458,321 | $3.10 M | 298.48% | 0.16% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 451,745 | $3.05 M | -7.79% | 0.16% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 410,286 | $2.77 M | 0.32% | 0.15% |
| BELLEVUE GROUP AG | 02/14/2025 | 377,806 | $2.55 M | -3.84% | 0.13% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Recursion Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 344 institutional investors and hedge funds held shares of Recursion Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 34.01 M
ARK Investment Management LLC: 32.35 M
BAILLIE GIFFORD & CO: 24.86 M
BlackRock Funding, Inc. /DE: 23.44 M
SOFTBANK GROUP CORP.: 14.67 M
Mubadala Investment Co PJSC: 12.99 M
107.83% of Recursion Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 314.38 M shares in the last 24 months. This purchase volume represents approximately $2.50 B in transactions.